Refractory acute myelogenous leukemia (AML)
Showing 1 - 25 of >10,000
AML Trial in Hangzhou (MAX-40279-01)
Recruiting
- AML
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University
Jan 18, 2022
Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in
Terminated
- Acute Myelogenous Leukemia in Relapse
- +4 more
-
Tucson, Arizona
- +12 more
Aug 18, 2022
Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)
Recruiting
- Neoplasms
- +2 more
- RD13-02 cell infusion
-
Xuzhou, Jiangsu, ChinaAffiliated hospital of Xuzhou medical college
Jun 7, 2023
Leukemia, Myeloid, Acute, Relapsed Adult AML, Refractory Leukemia Trial in Xiamen (venetoclax combining chidamide and
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- venetoclax combining chidamide and azacitidine (VCA)
-
Xiamen, Fujian, ChinaBing Xu
Aug 1, 2022
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in
Recruiting
- Acute Biphenotypic Leukemia
- +13 more
- Cladribine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2023
Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood Trial in United States (AC220, Cytarabine,
Completed
- Lymphoblastic Leukemia, Acute, Childhood
- Myelogenous Leukemia, Acute, Childhood
- AC220
- +3 more
-
Los Angeles, California
- +10 more
Mar 24, 2022
Acute Myelogenous Leukemia Trial in Sacramento (Bortezomib, Doxil)
Completed
- Acute Myelogenous Leukemia
-
Sacramento, CaliforniaUniversity of California Comprehensive Cancer Center
Feb 4, 2021
Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional
Active, not recruiting
- Acute Myeloid Leukemia
- +8 more
- Iomab-B
- +2 more
-
Gilbert, Arizona
- +23 more
Feb 22, 2022
Myelogenous Leukemia, Acute Trial in Ramat Gan (Bisantrene, Fludarabine, Clofarabine)
Recruiting
- Myelogenous Leukemia, Acute
- Bisantrene
- +2 more
-
Ramat Gan, IsraelChaim Sheba Medical Center
Sep 21, 2021
Leukemia Trial in Duarte (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- cyclophosphamide
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Refractory Acute Myelogenous Leukemia, Relapsed Acute Myelogenous Leukemia Trial in Minneapolis (FATE-NK100)
Completed
- Refractory Acute Myelogenous Leukemia
- Relapsed Acute Myelogenous Leukemia
- FATE-NK100
-
Minneapolis, MinnesotaUniversity of Minnesota, Masonic Cancer Center
Mar 10, 2021
Acute Myelogenous Leukemia, Allogeneic Stem Cell Transplantation Trial in Ramat Gan (Bisantrene)
Completed
- Acute Myelogenous Leukemia
- Allogeneic Stem Cell Transplantation
-
Ramat Gan, IsraelChaim Sheba Medical Center
Aug 6, 2020
Leukemia, Acute Lymphocytic (ALL), Leukemia, Acute Myelogenous (AML), MDS Trial in Guangzhou (Chimeric antigen receptor T cells,
Recruiting
- Leukemia, Acute Lymphocytic (ALL)
- +2 more
- Chimeric antigen receptor T cells
- peptide specific dendritic cell
-
Guangzhou, Guangdong, ChinaZhujiang Hospital, Southern Medical University
Aug 1, 2021
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)
Recruiting
- Acute Myeloid Leukemia Refractory
- Acute Myeloid Leukemia, in Relapse
- anti Tim-3/CD123 CAR-T cell therapy
-
Xuzhou, Jiangsu, ChinaKailin Xu
Nov 4, 2023
Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)
Completed
- Acute Myelogenous Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 4, 2023
AML, Adult Trial in Hangzhou (CLL1 CAR-NK cell injection)
Recruiting
- AML, Adult
- CLL1 CAR-NK cell injection
-
Hangzhou, Zhejiang, ChinaClinical research ethics committee of the first affiliated hospi
Aug 30, 2023
Acute Myelogenous Leukemia, MDS, Leukemia Trial in Miami (Tranylcypromine, Tretinoin)
Completed
- Acute Myelogenous Leukemia
- +2 more
-
Miami, FloridaUniversity of Miami
Jul 20, 2020
Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)
Not yet recruiting
- Relapsed/Refractory AML
- Selinexor
- +6 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Mar 28, 2023
Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)
Recruiting
- Acute Myeloid Leukemia
- CIML-NK Cells
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jan 4, 2023
Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone
Withdrawn
- Drug/Agent Toxicity by Tissue/Organ
- +3 more
- amifostine trihydrate
- +2 more
-
Chicago, Illinois
- +3 more
Jan 31, 2023
AML, B-ALL, T-ALL Trial in Memphis (CD123-CAR T, Cyclophosphamide, Fludarabine)
Recruiting
- AML
- +4 more
- CD123-CAR T
- +4 more
-
Memphis, Tennessee
- +1 more
May 10, 2022